Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disorders Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Age Related Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Ocular Inflammatory Disease (Uveitis)
1.2.5 Macular Hole
1.3 Market by Application
1.3.1 Global Retinal Disorders Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retinal Disorders Therapy Market Perspective (2018-2029)
2.2 Global Retinal Disorders Therapy Growth Trends by Region
2.2.1 Retinal Disorders Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Retinal Disorders Therapy Historic Market Size by Region (2018-2024)
2.2.3 Retinal Disorders Therapy Forecasted Market Size by Region (2024-2029)
2.3 Retinal Disorders Therapy Market Dynamics
2.3.1 Retinal Disorders Therapy Industry Trends
2.3.2 Retinal Disorders Therapy Market Drivers
2.3.3 Retinal Disorders Therapy Market Challenges
2.3.4 Retinal Disorders Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Retinal Disorders Therapy by Players
3.1.1 Global Retinal Disorders Therapy Revenue by Players (2018-2024)
3.1.2 Global Retinal Disorders Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Retinal Disorders Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Retinal Disorders Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Retinal Disorders Therapy Market Concentration Ratio
3.4.1 Global Retinal Disorders Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorders Therapy Revenue in 2022
3.5 Global Key Players of Retinal Disorders Therapy Head office and Area Served
3.6 Global Key Players of Retinal Disorders Therapy, Product and Application
3.7 Global Key Players of Retinal Disorders Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Disorders Therapy Breakdown Data by Type
4.1 Global Retinal Disorders Therapy Historic Market Size by Type (2018-2024)
4.2 Global Retinal Disorders Therapy Forecasted Market Size by Type (2024-2029)
5 Retinal Disorders Therapy Breakdown Data by Application
5.1 Global Retinal Disorders Therapy Historic Market Size by Application (2018-2024)
5.2 Global Retinal Disorders Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Retinal Disorders Therapy Market Size (2018-2029)
6.2 North America Retinal Disorders Therapy Market Size by Type
6.2.1 North America Retinal Disorders Therapy Market Size by Type (2018-2024)
6.2.2 North America Retinal Disorders Therapy Market Size by Type (2024-2029)
6.2.3 North America Retinal Disorders Therapy Market Share by Type (2018-2029)
6.3 North America Retinal Disorders Therapy Market Size by Application
6.3.1 North America Retinal Disorders Therapy Market Size by Application (2018-2024)
6.3.2 North America Retinal Disorders Therapy Market Size by Application (2024-2029)
6.3.3 North America Retinal Disorders Therapy Market Share by Application (2018-2029)
6.4 North America Retinal Disorders Therapy Market Size by Country
6.4.1 North America Retinal Disorders Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Retinal Disorders Therapy Market Size by Country (2018-2024)
6.4.3 North America Retinal Disorders Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Retinal Disorders Therapy Market Size (2018-2029)
7.2 Europe Retinal Disorders Therapy Market Size by Type
7.2.1 Europe Retinal Disorders Therapy Market Size by Type (2018-2024)
7.2.2 Europe Retinal Disorders Therapy Market Size by Type (2024-2029)
7.2.3 Europe Retinal Disorders Therapy Market Share by Type (2018-2029)
7.3 Europe Retinal Disorders Therapy Market Size by Application
7.3.1 Europe Retinal Disorders Therapy Market Size by Application (2018-2024)
7.3.2 Europe Retinal Disorders Therapy Market Size by Application (2024-2029)
7.3.3 Europe Retinal Disorders Therapy Market Share by Application (2018-2029)
7.4 Europe Retinal Disorders Therapy Market Size by Country
7.4.1 Europe Retinal Disorders Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Retinal Disorders Therapy Market Size by Country (2018-2024)
7.4.3 Europe Retinal Disorders Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Retinal Disorders Therapy Market Size (2018-2029)
8.2 China Retinal Disorders Therapy Market Size by Type
8.2.1 China Retinal Disorders Therapy Market Size by Type (2018-2024)
8.2.2 China Retinal Disorders Therapy Market Size by Type (2024-2029)
8.2.3 China Retinal Disorders Therapy Market Share by Type (2018-2029)
8.3 China Retinal Disorders Therapy Market Size by Application
8.3.1 China Retinal Disorders Therapy Market Size by Application (2018-2024)
8.3.2 China Retinal Disorders Therapy Market Size by Application (2024-2029)
8.3.3 China Retinal Disorders Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Retinal Disorders Therapy Market Size (2018-2029)
9.2 Asia Retinal Disorders Therapy Market Size by Type
9.2.1 Asia Retinal Disorders Therapy Market Size by Type (2018-2024)
9.2.2 Asia Retinal Disorders Therapy Market Size by Type (2024-2029)
9.2.3 Asia Retinal Disorders Therapy Market Share by Type (2018-2029)
9.3 Asia Retinal Disorders Therapy Market Size by Application
9.3.1 Asia Retinal Disorders Therapy Market Size by Application (2018-2024)
9.3.2 Asia Retinal Disorders Therapy Market Size by Application (2024-2029)
9.3.3 Asia Retinal Disorders Therapy Market Share by Application (2018-2029)
9.4 Asia Retinal Disorders Therapy Market Size by Region
9.4.1 Asia Retinal Disorders Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Retinal Disorders Therapy Market Size by Region (2018-2024)
9.4.3 Asia Retinal Disorders Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 ALLERGAN
11.1.1 ALLERGAN Company Details
11.1.2 ALLERGAN Business Overview
11.1.3 ALLERGAN Retinal Disorders Therapy Introduction
11.1.4 ALLERGAN Revenue in Retinal Disorders Therapy Business (2018-2024)
11.1.5 ALLERGAN Recent Developments
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Retinal Disorders Therapy Introduction
11.2.4 AbbVie Revenue in Retinal Disorders Therapy Business (2018-2024)
11.2.5 AbbVie Recent Developments
11.3 Alimera Sciences
11.3.1 Alimera Sciences Company Details
11.3.2 Alimera Sciences Business Overview
11.3.3 Alimera Sciences Retinal Disorders Therapy Introduction
11.3.4 Alimera Sciences Revenue in Retinal Disorders Therapy Business (2018-2024)
11.3.5 Alimera Sciences Recent Developments
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Details
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Retinal Disorders Therapy Introduction
11.4.4 Janssen Biotech Revenue in Retinal Disorders Therapy Business (2018-2024)
11.4.5 Janssen Biotech Recent Developments
11.5 Swedish Orphan Biovitrum
11.5.1 Swedish Orphan Biovitrum Company Details
11.5.2 Swedish Orphan Biovitrum Business Overview
11.5.3 Swedish Orphan Biovitrum Retinal Disorders Therapy Introduction
11.5.4 Swedish Orphan Biovitrum Revenue in Retinal Disorders Therapy Business (2018-2024)
11.5.5 Swedish Orphan Biovitrum Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Retinal Disorders Therapy Introduction
11.6.4 Roche Revenue in Retinal Disorders Therapy Business (2018-2024)
11.6.5 Roche Recent Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Retinal Disorders Therapy Introduction
11.7.4 Bristol-Myers Squibb Revenue in Retinal Disorders Therapy Business (2018-2024)
11.7.5 Bristol-Myers Squibb Recent Developments
11.8 Genzyme
11.8.1 Genzyme Company Details
11.8.2 Genzyme Business Overview
11.8.3 Genzyme Retinal Disorders Therapy Introduction
11.8.4 Genzyme Revenue in Retinal Disorders Therapy Business (2018-2024)
11.8.5 Genzyme Recent Developments
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Retinal Disorders Therapy Introduction
11.9.4 Genentech Revenue in Retinal Disorders Therapy Business (2018-2024)
11.9.5 Genentech Recent Developments
11.10 OCULAR THERAPEUTIX
11.10.1 OCULAR THERAPEUTIX Company Details
11.10.2 OCULAR THERAPEUTIX Business Overview
11.10.3 OCULAR THERAPEUTIX Retinal Disorders Therapy Introduction
11.10.4 OCULAR THERAPEUTIX Revenue in Retinal Disorders Therapy Business (2018-2024)
11.10.5 OCULAR THERAPEUTIX Recent Developments
11.11 Bausch & Lomb
11.11.1 Bausch & Lomb Company Details
11.11.2 Bausch & Lomb Business Overview
11.11.3 Bausch & Lomb Retinal Disorders Therapy Introduction
11.11.4 Bausch & Lomb Revenue in Retinal Disorders Therapy Business (2018-2024)
11.11.5 Bausch & Lomb Recent Developments
11.12 UCBCares
11.12.1 UCBCares Company Details
11.12.2 UCBCares Business Overview
11.12.3 UCBCares Retinal Disorders Therapy Introduction
11.12.4 UCBCares Revenue in Retinal Disorders Therapy Business (2018-2024)
11.12.5 UCBCares Recent Developments
11.13 Aier Eye Hospital
11.13.1 Aier Eye Hospital Company Details
11.13.2 Aier Eye Hospital Business Overview
11.13.3 Aier Eye Hospital Retinal Disorders Therapy Introduction
11.13.4 Aier Eye Hospital Revenue in Retinal Disorders Therapy Business (2018-2024)
11.13.5 Aier Eye Hospital Recent Developments
11.14 Alcon Holdings, Inc.
11.14.1 Alcon Holdings, Inc. Company Details
11.14.2 Alcon Holdings, Inc. Business Overview
11.14.3 Alcon Holdings, Inc. Retinal Disorders Therapy Introduction
11.14.4 Alcon Holdings, Inc. Revenue in Retinal Disorders Therapy Business (2018-2024)
11.14.5 Alcon Holdings, Inc. Recent Developments
11.15 Eyebright Medical
11.15.1 Eyebright Medical Company Details
11.15.2 Eyebright Medical Business Overview
11.15.3 Eyebright Medical Retinal Disorders Therapy Introduction
11.15.4 Eyebright Medical Revenue in Retinal Disorders Therapy Business (2018-2024)
11.15.5 Eyebright Medical Recent Developments
11.16 Kanghong Pharmaceutical
11.16.1 Kanghong Pharmaceutical Company Details
11.16.2 Kanghong Pharmaceutical Business Overview
11.16.3 Kanghong Pharmaceutical Retinal Disorders Therapy Introduction
11.16.4 Kanghong Pharmaceutical Revenue in Retinal Disorders Therapy Business (2018-2024)
11.16.5 Kanghong Pharmaceutical Recent Developments
11.17 Huaxia Eye Hospital
11.17.1 Huaxia Eye Hospital Company Details
11.17.2 Huaxia Eye Hospital Business Overview
11.17.3 Huaxia Eye Hospital Retinal Disorders Therapy Introduction
11.17.4 Huaxia Eye Hospital Revenue in Retinal Disorders Therapy Business (2018-2024)
11.17.5 Huaxia Eye Hospital Recent Developments
11.18 Xingqi Pharmaceutical
11.18.1 Xingqi Pharmaceutical Company Details
11.18.2 Xingqi Pharmaceutical Business Overview
11.18.3 Xingqi Pharmaceutical Retinal Disorders Therapy Introduction
11.18.4 Xingqi Pharmaceutical Revenue in Retinal Disorders Therapy Business (2018-2024)
11.18.5 Xingqi Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Retinal Disorders Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Age Related Macular Degeneration
Table 3. Key Players of Diabetic Retinopathy
Table 4. Key Players of Ocular Inflammatory Disease (Uveitis)
Table 5. Key Players of Macular Hole
Table 6. Global Retinal Disorders Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Retinal Disorders Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Retinal Disorders Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Retinal Disorders Therapy Market Share by Region (2018-2024)
Table 10. Global Retinal Disorders Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Retinal Disorders Therapy Market Share by Region (2024-2029)
Table 12. Retinal Disorders Therapy Market Trends
Table 13. Retinal Disorders Therapy Market Drivers
Table 14. Retinal Disorders Therapy Market Challenges
Table 15. Retinal Disorders Therapy Market Restraints
Table 16. Global Retinal Disorders Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Retinal Disorders Therapy Revenue Share by Players (2018-2024)
Table 18. Global Top Retinal Disorders Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Therapy as of 2022)
Table 19. Global Retinal Disorders Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Retinal Disorders Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Retinal Disorders Therapy, Headquarters and Area Served
Table 22. Global Key Players of Retinal Disorders Therapy, Product and Application
Table 23. Global Key Players of Retinal Disorders Therapy, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinal Disorders Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Retinal Disorders Therapy Revenue Market Share by Type (2018-2024)
Table 27. Global Retinal Disorders Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Retinal Disorders Therapy Revenue Market Share by Type (2024-2029)
Table 29. Global Retinal Disorders Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Retinal Disorders Therapy Revenue Share by Application (2018-2024)
Table 31. Global Retinal Disorders Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Retinal Disorders Therapy Revenue Share by Application (2024-2029)
Table 33. North America Retinal Disorders Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Retinal Disorders Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Retinal Disorders Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Retinal Disorders Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Retinal Disorders Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Retinal Disorders Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Retinal Disorders Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Retinal Disorders Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Retinal Disorders Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Retinal Disorders Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Retinal Disorders Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Retinal Disorders Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Retinal Disorders Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Retinal Disorders Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Retinal Disorders Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Retinal Disorders Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Retinal Disorders Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Retinal Disorders Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Retinal Disorders Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Retinal Disorders Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Retinal Disorders Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Retinal Disorders Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Retinal Disorders Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Retinal Disorders Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Retinal Disorders Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Retinal Disorders Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 65. ALLERGAN Company Details
Table 66. ALLERGAN Business Overview
Table 67. ALLERGAN Retinal Disorders Therapy Product
Table 68. ALLERGAN Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 69. ALLERGAN Recent Developments
Table 70. AbbVie Company Details
Table 71. AbbVie Business Overview
Table 72. AbbVie Retinal Disorders Therapy Product
Table 73. AbbVie Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 74. AbbVie Recent Developments
Table 75. Alimera Sciences Company Details
Table 76. Alimera Sciences Business Overview
Table 77. Alimera Sciences Retinal Disorders Therapy Product
Table 78. Alimera Sciences Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 79. Alimera Sciences Recent Developments
Table 80. Janssen Biotech Company Details
Table 81. Janssen Biotech Business Overview
Table 82. Janssen Biotech Retinal Disorders Therapy Product
Table 83. Janssen Biotech Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 84. Janssen Biotech Recent Developments
Table 85. Swedish Orphan Biovitrum Company Details
Table 86. Swedish Orphan Biovitrum Business Overview
Table 87. Swedish Orphan Biovitrum Retinal Disorders Therapy Product
Table 88. Swedish Orphan Biovitrum Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 89. Swedish Orphan Biovitrum Recent Developments
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Retinal Disorders Therapy Product
Table 93. Roche Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 94. Roche Recent Developments
Table 95. Bristol-Myers Squibb Company Details
Table 96. Bristol-Myers Squibb Business Overview
Table 97. Bristol-Myers Squibb Retinal Disorders Therapy Product
Table 98. Bristol-Myers Squibb Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 99. Bristol-Myers Squibb Recent Developments
Table 100. Genzyme Company Details
Table 101. Genzyme Business Overview
Table 102. Genzyme Retinal Disorders Therapy Product
Table 103. Genzyme Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 104. Genzyme Recent Developments
Table 105. Genentech Company Details
Table 106. Genentech Business Overview
Table 107. Genentech Retinal Disorders Therapy Product
Table 108. Genentech Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 109. Genentech Recent Developments
Table 110. OCULAR THERAPEUTIX Company Details
Table 111. OCULAR THERAPEUTIX Business Overview
Table 112. OCULAR THERAPEUTIX Retinal Disorders Therapy Product
Table 113. OCULAR THERAPEUTIX Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 114. OCULAR THERAPEUTIX Recent Developments
Table 115. Bausch & Lomb Company Details
Table 116. Bausch & Lomb Business Overview
Table 117. Bausch & Lomb Retinal Disorders Therapy Product
Table 118. Bausch & Lomb Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 119. Bausch & Lomb Recent Developments
Table 120. UCBCares Company Details
Table 121. UCBCares Business Overview
Table 122. UCBCares Retinal Disorders Therapy Product
Table 123. UCBCares Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 124. UCBCares Recent Developments
Table 125. Aier Eye Hospital Company Details
Table 126. Aier Eye Hospital Business Overview
Table 127. Aier Eye Hospital Retinal Disorders Therapy Product
Table 128. Aier Eye Hospital Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 129. Aier Eye Hospital Recent Developments
Table 130. Alcon Holdings, Inc. Company Details
Table 131. Alcon Holdings, Inc. Business Overview
Table 132. Alcon Holdings, Inc. Retinal Disorders Therapy Product
Table 133. Alcon Holdings, Inc. Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 134. Alcon Holdings, Inc. Recent Developments
Table 135. Eyebright Medical Company Details
Table 136. Eyebright Medical Business Overview
Table 137. Eyebright Medical Retinal Disorders Therapy Product
Table 138. Eyebright Medical Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 139. Eyebright Medical Recent Developments
Table 140. Kanghong Pharmaceutical Company Details
Table 141. Kanghong Pharmaceutical Business Overview
Table 142. Kanghong Pharmaceutical Retinal Disorders Therapy Product
Table 143. Kanghong Pharmaceutical Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 144. Kanghong Pharmaceutical Recent Developments
Table 145. Huaxia Eye Hospital Company Details
Table 146. Huaxia Eye Hospital Business Overview
Table 147. Huaxia Eye Hospital Retinal Disorders Therapy Product
Table 148. Huaxia Eye Hospital Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 149. Huaxia Eye Hospital Recent Developments
Table 150. Xingqi Pharmaceutical Company Details
Table 151. Xingqi Pharmaceutical Business Overview
Table 152. Xingqi Pharmaceutical Retinal Disorders Therapy Product
Table 153. Xingqi Pharmaceutical Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 154. Xingqi Pharmaceutical Recent Developments
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Disorders Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Retinal Disorders Therapy Market Share by Type: 2022 VS 2029
Figure 3. Age Related Macular Degeneration Features
Figure 4. Diabetic Retinopathy Features
Figure 5. Ocular Inflammatory Disease (Uveitis) Features
Figure 6. Macular Hole Features
Figure 7. Global Retinal Disorders Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Retinal Disorders Therapy Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Retinal Disorders Therapy Report Years Considered
Figure 13. Global Retinal Disorders Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Retinal Disorders Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Retinal Disorders Therapy Market Share by Region: 2022 VS 2029
Figure 16. Global Retinal Disorders Therapy Market Share by Players in 2022
Figure 17. Global Top Retinal Disorders Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Retinal Disorders Therapy Revenue in 2022
Figure 19. North America Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Retinal Disorders Therapy Market Share by Type (2018-2029)
Figure 21. North America Retinal Disorders Therapy Market Share by Application (2018-2029)
Figure 22. North America Retinal Disorders Therapy Market Share by Country (2018-2029)
Figure 23. United States Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Retinal Disorders Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Retinal Disorders Therapy Market Share by Type (2018-2029)
Figure 27. Europe Retinal Disorders Therapy Market Share by Application (2018-2029)
Figure 28. Europe Retinal Disorders Therapy Market Share by Country (2018-2029)
Figure 29. Germany Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Retinal Disorders Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Retinal Disorders Therapy Market Share by Type (2018-2029)
Figure 37. China Retinal Disorders Therapy Market Share by Application (2018-2029)
Figure 38. Asia Retinal Disorders Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Retinal Disorders Therapy Market Share by Type (2018-2029)
Figure 40. Asia Retinal Disorders Therapy Market Share by Application (2018-2029)
Figure 41. Asia Retinal Disorders Therapy Market Share by Region (2018-2029)
Figure 42. Japan Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Retinal Disorders Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Retinal Disorders Therapy Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Retinal Disorders Therapy Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Retinal Disorders Therapy Market Share by Country (2018-2029)
Figure 52. Brazil Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. ALLERGAN Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 59. AbbVie Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 60. Alimera Sciences Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 61. Janssen Biotech Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 62. Swedish Orphan Biovitrum Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 63. Roche Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 65. Genzyme Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 66. Genentech Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 67. OCULAR THERAPEUTIX Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 68. Bausch & Lomb Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 69. UCBCares Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 70. Aier Eye Hospital Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 71. Alcon Holdings, Inc. Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 72. Eyebright Medical Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 73. Kanghong Pharmaceutical Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 74. Huaxia Eye Hospital Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 75. Xingqi Pharmaceutical Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed